CHCL logo

Cian Healthcare Ltd

CHCLBSE
₹33.49▲ +0.65 (+1.98%)
Mkt cap₹84 Cr
P/E—
Volume411
Day range33.49 – 33.49
52W range7.5 – 111.66

Cian Healthcare Ltd (CHCL): company summary

The company's business is deteriorating, with annual revenue falling 8.1% to ₹28 crore and annual net profit turning from a loss of ₹26 crore to a loss of ₹23 crore.

Cian Healthcare Ltd (CHCL) is a micro-cap Healthcare company valued at ₹84 crore operating in Pharmaceuticals & Biotechnology on the NSE and BSE.

Recent price move
Cian Healthcare Ltd last traded at ₹33.49, modestly up 1.98% on the day.
Financial performance
The company's business is deteriorating, with annual revenue falling 8.1% to ₹28 crore and annual net profit turning from a loss of ₹26 crore to a loss of ₹23 crore. The latest quarter saw revenue rise 41.7% year-on-year to ₹17 crore, but the net loss widened to ₹18 crore from ₹8 crore, indicating persistent cost pressures.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 7.17 times book value.
Things to watch
The company is highly leveraged with debt to equity at 3.36, and reported a net loss of ₹23 crore in its latest financial year. The stock is 74.9% below its 52-week high, and the net profit margin improved only slightly to -82.3%.
Where it stands
The company remains in a net loss position with a high debt to equity ratio and a stock price far below its 52-week high. The most significant movement was the widening net loss in the latest quarter, which highlights ongoing challenges in profitability.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Price performance

52W₹7.50
₹111.66

Key numbers

Price-based figures are live; statement figures are from FY26, consolidated where filed.

Valuation

Market cap
₹84 Cr
P/E
—
P/B
7.2×
P/S
—
EV/EBITDA
—
Earnings yield
—
Dividend yield
—
Fair value

Profitability

ROE
-49.2%
ROCE
-61.7%
ROIC
-47.8%
ROA
-37.8%
Gross margin
20.4%
Operating margin
-24.5%
Net margin
-82.3%
EPS (TTM/FY)
₹-9.32

Growth

Sales · last qtr YoY
—
Profit · last qtr YoY
—
Sales · 1Y
−8.1%
Profit · 1Y
+10.4%
Sales CAGR · 3Y / 5Y
−26% / −17%
Profit CAGR · 3Y / 5Y
— / —
EPS CAGR · 5Y
—
Sales CAGR · 10Y
—

Balance sheet

Debt / equity
3.36
Net debt / EBITDA
-3.97×
Interest cover
-107.1×
Current ratio
0.78
Total debt
₹29 Cr
Cash
₹1 Cr
Book value / share
₹3.4
Free cash flow
₹12 Cr

Quality & trading

Piotroski F-score
4 / 9
Altman Z
-2.58
Cash conversion cycle
26 days
Dividend payout
0%
Delivery %
100.0%
Volume vs 30D avg
0.37×
Avg traded value
₹0 Cr/day
Face value
₹10.00

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals & Biotechnology

Cian Healthcare Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.